Innospec Inc. (NASDAQ:IOSP) Shares Bought by Leeward Investments LLC MA

Leeward Investments LLC MA increased its position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 22.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,004 shares of the specialty chemicals company's stock after purchasing an additional 15,750 shares during the period. Leeward Investments LLC MA owned 0.34% of Innospec worth $9,726,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of IOSP. Assenagon Asset Management S.A. grew its holdings in Innospec by 98.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 120,082 shares of the specialty chemicals company's stock valued at $14,841,000 after buying an additional 59,554 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in Innospec by 33.1% in the 1st quarter. BNP Paribas Financial Markets now owns 25,063 shares of the specialty chemicals company's stock valued at $3,232,000 after acquiring an additional 6,237 shares during the last quarter. Vanguard Group Inc. increased its holdings in Innospec by 5.5% in the 1st quarter. Vanguard Group Inc. now owns 3,115,167 shares of the specialty chemicals company's stock valued at $401,670,000 after acquiring an additional 161,249 shares during the last quarter. Sei Investments Co. lifted its stake in Innospec by 4.9% in the 1st quarter. Sei Investments Co. now owns 138,788 shares of the specialty chemicals company's stock worth $17,895,000 after purchasing an additional 6,532 shares in the last quarter. Finally, SG Americas Securities LLC boosted its holdings in shares of Innospec by 660.1% during the 2nd quarter. SG Americas Securities LLC now owns 9,767 shares of the specialty chemicals company's stock valued at $1,207,000 after purchasing an additional 8,482 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Stock Down 3.9 %

Innospec stock traded down $4.90 during mid-day trading on Thursday, reaching $120.00. 200,912 shares of the company's stock traded hands, compared to its average volume of 107,424. Innospec Inc. has a 12-month low of $100.50 and a 12-month high of $133.71. The stock has a 50 day moving average of $111.48 and a two-hundred day moving average of $118.83. The company has a market cap of $2.99 billion, a price-to-earnings ratio of 20.10 and a beta of 1.08.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 EPS for the quarter, meeting analysts' consensus estimates of $1.35. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The firm had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. During the same quarter last year, the firm earned $1.59 EPS. The firm's revenue for the quarter was down 4.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Innospec Inc. will post 5.92 earnings per share for the current year.

Innospec Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th will be given a dividend of $0.79 per share. This is a boost from Innospec's previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend is Monday, November 18th. This represents a yield of 1.3%. Innospec's payout ratio is 25.46%.

Analyst Ratings Changes

Separately, StockNews.com downgraded Innospec from a "strong-buy" rating to a "buy" rating in a research report on Thursday, August 8th.

Insider Transactions at Innospec

In related news, CFO Ian Cleminson sold 3,398 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $114.74, for a total transaction of $389,886.52. Following the completion of the sale, the chief financial officer now directly owns 12,996 shares of the company's stock, valued at approximately $1,491,161.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.35% of the company's stock.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.